Macaulay Capital PLC Extension of warrant exercise date & Director loan
26 Julio 2024 - 1:00AM
RNS Regulatory News
RNS Number : 9072X
Macaulay Capital PLC
26 July 2024
26 July 2024
Macaulay Capital
PLC
("Macaulay Capital" or the "Company")
Extension of warrant exercise
date and Director loan
Macaulay Capital PLC (AQSE:MCAP),
which was formed to originate and manage corporate transactions,
raise funds from third parties, invest its own funds alongside
those of external investors and to manage its investment portfolio
with the aim of maximising its value, announces the extension of
the exercise date for certain warrants and also a loan to be made
to the Company by its Managing Director, David Horner.
As set out in the Company's AQSE admission
document dated 25 July 2022, Harry and Tom Horner (the adult sons
of David Horner) each hold 3,000,000 warrants ("Unconditional
Founder Warrants") that were required to be exercised at a
subscription price of £0.25 per share by the date two years from
the Company's admission to trading on AQSE (29 July 2024). The
Company has agreed to extend the date by which the Unconditional
Founder Warrants must be exercised to 31 December 2024 ("Warrant
Extension").
In addition, David Horner has agreed to lend
the Company £500,000 (the "Loan") for working capital and other
purposes. The Loan is unsecured and ranks alongside the
Company's ordinary shares, is interest free and is repayable on or
before 31 December 2024 from the proceeds of the exercise of the
Unconditional Founder Warrants.
As David Horner is a director of the Company
and Harry and Tom Horner are both substantial shareholders, the
Warrant Extension and the Loan are deemed to be related party
transactions under the AQSE Rules. The Company's other
directors, Lindsay Mair and Richard Bucknell, having exercised
reasonable care, skill and diligence, believe that the Warrant
Extension and the Loan are fair and reasonable as far as the
shareholders of the Company are concerned.
This announcement contains
inside information for the purposes of the UK Market Abuse
Regulation and the Directors of the Company are responsible for the
release of this announcement.
ENDS
Enquiries:
|
Macaulay Capital
PLC
|
|
|
Clive Milner
|
+44 (0)20 3946 5980
|
|
|
|
|
Cairn Financial Advisers LLP (AQSE Corporate
Adviser)
|
|
|
Louise O'Driscoll
|
+44 (0)20 7213 0880
|
|
Oberon Capital (Broker)
|
|
|
Chris Crawford
|
+44 (0)20 3179 5304
|
For
more information please visit: www.macaulaycapital.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXRAMATMTITBLI
Macaulay Capital (AQSE:MCAP)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Macaulay Capital (AQSE:MCAP)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024
